Raquel Monge Carmona

Ms. Raquel Monge Carmona

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2024 in Eye
Verified
Journal Article
Closed access
PDF file
RCRaquel Monge Carmona
Raquel Monge Carmona
MCManuel Caro-Magdaleno
Manuel Caro-Magdaleno
MSMaría Carmen Sánchez-González
María Carmen Sánchez-González

27 August 2024 in Prosthesis
Verified
Journal Article
Open access
PDF file
AGAntonio Manuel Garrido-Hermosilla
Antonio Manuel Garrido-Hermosilla
IMIrene Martinez-Alberquilla
Irene Martinez-Alberquilla
MDMaría Concepción Díaz-Ruiz
María Concepción Díaz-Ruiz
RCRaquel Monge Carmona
Raquel Monge Carmona
MMMariola Méndez-Muros
Mariola Méndez-Muros
EREnrique Rodríguez-De-La-Rúa-Franch
Enrique Rodríguez-De-La-Rúa-Franch
Objectives: To assess the overall mental health of enucleated or eviscerated patients after high-density porous polyethylene OCULFIT implantation and external prosthesis over a 1-year follow-up. Methods: Patients with an indication of enucleation or evisceration with OCULFIT implantation were included in a prospective study. The patients completed four questionnaires regarding mental health at three different visits (baseline, 3–6 months, and 9–12 months post-surgery). The questionnaires used were the following: SF-12 for multidimensional health-related quality of life (scale 0–100); Rosemberg self-esteem scale (scale 0–40); Patients Health Questionnaire-4 (PHQ-4) (scale 0–6); and a Lifetime Major Depression and Anhedonia questionnaire (categorised in groups with/without symptoms). Results: A total of 33 patients (16 enucleations and 17 eviscerations) were included in the study. The physical domain of the SF-12 questionnaire did not change between visits, but the mental domain significantly improved from the baseline to the last visit (41.71 ± 12.72 vs. 46.80 ± 10.68, p = 0.04). The number of patients with high, moderate, and low self-esteem (Rosemberg scale) was similar between the baseline and the last visit. The depression and anxiety scores of the PHQ-4 were not significantly different among visits. The number of patients with no symptoms (depression or anhedonia) improved from the baseline (42.2%) throughout the follow-up (66.7% at the last visit). Conclusions: OCULFIT orbital implant and external prosthesis placement maintained and/or improved the quality of life related to mental health in eviscerated and enucleated eyes. The number of patients with no symptoms improved from the baseline throughout the follow-up. The patients’ self-esteem was already high before implantation and remained stable over the follow-up.

27 November 2024 in Prosthesis
Verified
Journal Article
Open access
PDF file
AGAntonio Manuel Garrido-Hermosilla
Antonio Manuel Garrido-Hermosilla
IMIrene Martinez-Alberquilla
Irene Martinez-Alberquilla
MDMaría Concepción Díaz-Ruiz
María Concepción Díaz-Ruiz
RCRaquel Monge Carmona
Raquel Monge Carmona
MMMariola Méndez-Muros
Mariola Méndez-Muros
EREnrique Rodríguez-De-La-Rúa-Franch
Enrique Rodríguez-De-La-Rúa-Franch
OBJECTIVES: To describe our experience with a new high-density porous polyethylene orbital implant post-enucleation and evisceration and comment on their performance and safety. METHODS: Patients with an indication of enucleation or evisceration with orbital implantation were included in a prospective study. All patients were implanted with OCULFIT orbital implants (AJL Ophthalmic S.A.) and followed up over 12 months. Anatomical and functional parameters, motility, and aesthetic appearance were evaluated. Patient satisfaction on a scale of 0 (very bad) to 5 (excellent), complications and success rates were reported. RESULTS: Overall, 16 enucleated and 17 eviscerated eyes were analyzed. Orbital implant motility was good for 93.8% and 100% of enucleated and eviscerated patients, respectively. No shortened fornixes were found after external prosthesis placement, and palpebral fissure, orbital volume, and lower eyelid laxity were symmetric with the contralateral eye for the vast majority. The aesthetic appearance was good for 87.5% and 100% of enucleated and eviscerated patients at the last visit with no differences between groups. Excellent satisfaction was reported for 100% and 94.1% of enucleated and eviscerated patients. Anatomical and functional success rates were 78.8% and 81.8%, respectively. No exposure, infection or complications related to surgery were reported during the follow-up. CONCLUSIONS: After 1 year of follow-up, OCULFIT orbital implants provide excellent patient satisfaction and performance in terms of motility and symmetry with the contralateral eye after external prosthesis placement with no complications related to the surgical procedure. No differences between enucleated and eviscerated eyes were found, and aesthetic results were remarkable for both groups. Conclusions should be interpreted with caution due to the small sample size.